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Summary 
We used gene targeting in embryonic stem cells to 
introduce an IL-lf3 null allele in mice. The IL-lft-defi- 
cient mice develop normally and are apparently healthy 
and fertile. The IL-18 null mice responded normally in 
models of contact and delayed-type hypersensitivity 
or followlng bacterial endotoxin LPS-induced inflam- 
mation. The IL-1%deficient mice showed equivalent 
resistance to Listeria monocytogenes compared with 
wild-type controls. In contrast, when challenged wlth 
turpentine, which causes localized Inflammation and 
tissue injury, the IL-lfl mutant mice exhibited an im- 
paired acute-phase inflammatory response and were 
completely resistant to fever development and an- 
orexia. These results highlight a central role for IL-lf3 
as a pyrogen and a mediator of the acute-phase re- 
sponse in a subset of inflammatory disease models, 
and support the notion that blocklng the action of a 
single key cytokine can alter the course of specific 
immune and inflammatory responses. 
introduction 
Mammalian interleukin-1 (IL-l) is a proinflammatory cyto- 
kine that is produced particularly by mononuclear phago- 
cytes, but also by numerous other cell types, in response 
to injury and infection (reviewed by di Giovine and Duff, 
1990; Dinarello, 1992; and references therein). The biolog- 
ical activity of IL-l is encoded bytwodistinct genes, termed 
IL-1 a and IL-1 fl, which share approximately 25% primary 
amino acid sequence identity. These two gene products, 
however, have similar three-dimensional structures, bind 
to the same receptors on target cells, and elicit identical 
biological responses (Sims et al., 1968; Chizzonite et al., 
1989). IL-la is believed to be the major form of IL-l re- 
leased from cells, while IL-la is thought to be primarily 
cell associated (Denczuk et al., 1987; Brody and Durum, 
1969). IL-la and IL-18 are both synthesized as 31.5 kDa 
precursor proteins, and are proteolytically cleaved to gen- 
erate mature proteins of 17 kDa (Cameron et al., 1986; 
Kosturaet al., 1989). Both pro-IL-la and mature IL-la are 
active, whereas precursor IL-lp is biologically inactive 
(Brody and Durum, 1989). The maturation of precursor 
IL-lp to its mature form involves an endoproteinase 
termed IL-lf3converting enzyme (ICE) (Thornberry et al., 
1992; Cerretti et al., 1992). 
IL-1 has been implicated in a broad spectrum of inflam- 
matory, physiologic, hematopoietic, and immunologic ac- 
tivities. It is believed to be a mediator of inflammation in 
both man and animal models and has been proposed as 
an attractive target for therapeutic intervention in the treat- 
ment of inflammatory diseases. IL-1 is produced in re- 
sponse to systemic and local inflammation and contributes 
to loss of body weight, anorexia, and hepatic acute-phase 
protein synthesis (Beiset, 1975; Kushner and Mackiewicz, 
1993). IL-1 has been shown to be an important endoge- 
nous pyrogen, since administration of recombinant IL-1 
results in an increase in body temperature and neutralizing 
antibodies against IL-18 partially inhibits lipopolysaccha- 
ride (LPS)-induced fever (Kluger, 1991; Long et al., 1990). 
Studies using neutralizing antibodies have shown that 
IL-l, in particular IL-la, is involved in the development 
and progression of collagen-induced arthritis (CIA) in mice 
(Geiger et al., 1993; Van den Berg et al., 1994). IL-lf3 is 
rapidly accumulated in Langerhans cells after exposure 
to contact allergens and is believed to play a critical role 
in the initiation of contact hypersensitivity (CH) responses 
in the skin (Enk and Katz, 1991; Enk et al., 1993). In con- 
trast with its role in inflammatory diseases, IL-1 has been 
implicated as a mediator in host defense (Van der Meer 
et al., 1988; Havetl et al., 1992). IL-1 has been shown to 
participate in the development of anti-Listeria responses in 
mice and administration of IL-1 prior to or during bacterial 
infection enhanced antimicrobial activity and survival (Van 
der Meer et al., 1988; Rogers et al., 1992). 
The expression of IL-l is under stringent control. IL-1 
activity is usually undetectable in normal biological fluids, 
but can be transiently induced in response to infection, 
inflammatory stimuli, and tissue injury. The activity of IL-l 
is regulated at the transcriptional, posttranscriptional, and 
posttranslational levels (reviewed by Fenton, 1992 and 
references therein). IL-1 interacts with cells through two 
classes of molecules: type I and type II receptors (Dower 
and Urdal, 1987). Although both IL-la and IL-lb bind the 
two receptors with similar affinities, the type II receptor 
:mgmunity 
may function as adecoy target for IL-1 and inhibit its biolog- 
ical activity (Colotta et al., 1993). In addition, a unique 
naturally occurring IL-1 receptor antagonist (IL-l ra) is ex- 
pressed by many cell types and functions as an IL-1 inhibi- 
tor by binding the IL-1 receptor without triggering any bio- 
logical response (Eisenberg et al., 1990). 
Although IL-1 is regarded mainly as an inducible gene, 
it is constitutively expressed in several tissues, such as 
skin keratinocytes and cells of central nervous system 
(CNS) origin. IL-1 8 activity can be detected in the hypothal- 
amus and may act as a neurotransmitter (Breder et al., 
1988). In addition, IL-1 is expressed during the preimplan- 
tation period, suggesting that it may play a role during 
early embryogenesis (McMaster et al., 1992; Rothstein et 
al., 1992). 
Despite extensive studies in vitro, the physiological im- 
portanceof IL-l in vivo remains largely unknown. The spe- 
cific function of IL-1 is further obscured by the fact that 
many of its activities overlap with those of other cytokines, 
primarily tumor necrosis factor-a (TNFa) and IL-8. These 
cytokines regulate one another to form a cytokine network 
(Akiraet al., 1990). For example, IL-l and TNFa are capa- 
ble of inducing each other and are both potent inducers 
of 11-8. To address unequivocally the in vivo function of 
IL-18 we produced an IL-1 P-deficient mouse strain by ho- 
mologous recombination. We show here that the IL-18 
null mice were unable to mount a normal acute-phase 
inflammatory response following turpentine injection, which 
causes localized leukocyte infiltration, edema and tissue 
damage. The loss of body weight and elevation of IL-8 level 
typically associated with this model were not observed 
in the mutant mice. Most dramatically, the IL-l P-deficient 
mice did not develop fever following turpentine adminis- 
tration. In contrast, the IL-l P-deficient mice responded 
similarly to wild-type controls in systemic inflammation in- 
duced by LPS injection, infection with L. monocytogenes, 
and in models of CH and delayed-type hypersensitivity 
(DTH). 
Results 
Generation of IL-1 B-Deficient Mice 
To generate a null allele of the IL-18 gene in mouse embry- 
onic stem (ES) cells, we constructed a targeting vector in 
which the first 8 of 7 exons of the IL-18 gene were deleted 
and replaced with the PGK-neo sequence (Figure 1A). 
The 5’ and 3’ homologies were 4.5 kb and 1.3 kb, respec- 
tively. The HSV-rk cassette was attached at the end of 
the 3’ homology for negative selection (Mansour et al., 
1988). The linearized vector was electroporated intoAB2.1 
mouse ES cells (Matzuk et al., 1992) and the transfected 
cells were selected in 6418 and FIAU. An &fold enrich- 
ment was achieved by FIAU counterselection as compared 
with G418 selection alone. G418 and FIAU-resistant colo- 
nies were expanded and analyzed by a mini-Southern pro- 
tocol (Ramfrez-Solis et al., 1992). A total of three targeted 
clones were identified from 350 double-resistant clones 
analyzed. Therefore, the frequency of targeted recombina- 
tion versus random integration at the IL-1 8 locus is 3/930. 
The homologous recombination events were identified by 
digestion of genomic DNA with EcoRl and Kpnl, followed 
by hybridization with an IL-1 8 probe (Figure 1A) in a South- 
ern blot analysis. The wild-type IL-1 8 allele displays a 7.8 
kb EcoRl fragment and a 10 kb Kpnl band. Correctly tar- 
geted recombination events would generate a 3.8 kb 
EcoRl fragment due to the deletion of the IL-18 gene and 
a 18 kb Kpnl band, since the Kpnl site inside the IL-18 
gene was mutated in the vector (Figure 1 B). Homologous 
recombination was also determined by hybridization with 
the neo sequence, which confirmed the occurrence of only 
a single integration event in these clones (data not shown). 
The targeted clones were injected into 3.5 dpc C57BU 
8J blastocysts to generate chimeras. A total of 9 male and 
3 female chimeras were produced with ES cell contribu- 
tions ranging from 80%-l OO%, as judged by the percent- 
age of agouti color in the chimeric mice. Male chimeras 
were bred to C57BU8J females to assess their potential 
for germline colonization. Clone 214 and 318 (data not 
shown) resulted in successful transmission of ES cells into 
the next generation, of which approximately 50% of the 
agouti pups contained the deleted IL-18 gene (data not 
shown). Mice generated from clone 214 were used as the 
focus for further study. Heterozygous mice were phenotyp- 
ically indistinguishable from their normal littermates. 
To produce mice homozygous for the disrupted IL-18 
allele, cross matings between heterozygous mice were 
set up. Normal litter sizes were observed. The resulting 
pups were genotyped by Southern blot analysis (Figure 
1C). Of 102 mice analyzed at 2 weeks of age, 23 (22.5%) 
were wild-type (+I+), 54 (53%) were heterozygous (+I-), 
and 25 (24.5%) were homozygous (-I-) for the deleted 
IL-1 8 gene, resulting in a normal 1:2:1 Mendelian distribu- 
tion of offspring. The ability to generate viable homozygous 
IL-18 knockout mice ruled out a nonredundant function 
for IL-1 8 during mouse embryogenesis. The homozygous 
IL-18 mutant mice were healthy and fertile in a specific 
pathogen-free environment. Fluorescence-activated cell 
sorter (FACS) analysis showed that the T and B cell lin- 
eages were not significantly affected in the IL-l 8 knockout 
mice. Detailed histopathological evaluation failed to reveal 
any abnormalities in the mutant mice (data not shown). 
LPS-Induced Expression of IL-18 
and Other Cytoklnes 
To determine whether a complete deficiency of IL-l 8 was 
produced in the mutant mice, we induced IL-l 8 expression 
by sensitizing the animals with 1 mg of heat-killed Propioni- 
bacterium acnes and by challenging them with an intra- 
peritoneal injection of 10 pg of bacterial endotoxin LPS 8 
days later. The mice were sacrificed 3 hr after challenge 
and blood and peritoneal lavage samples were obtained. 
Livers were taken for isolation of RNA, and Northern blot 
analysis was carried out by hybridizing the RNA samples 
with IL-l 8 cDNA (Figure 2). 
ELlSAs were performed on plasma and peritoneal la- 
vage samples to determine the levels of IL-15 as well as 
IL-la, IL-8, and TNFa. IL-1 8 protein could not be identified, 
although the levels of IL-1 a, 11-8, and TNFa were elevated 
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Figure 1. Generation of IL-lb-Deficient Mice by Gene Targeting in Mouse ES Cells 
(A) Targeted deletion of IL-lb gene in ES cells. The deletion targeting vector contained a 4.2 kb Bamlil fragment upstream of the ATG translation 
initiation codon and a 1.3 kb Kpnl-Bglll fragment containing exon 7 of the IL-1 B gene as homologous targeting sequences (represented by shaded 
rectangles). A 5.6 kb BamHI-Kpnl fragment from exon 1 to intron 6 of the IL-1 B gene was deleted and replaced with the positive selective marker 
PGK-neo (Rudnicki et al., 1992). which was inserted in the same orientation as the IL-lb gene. The PGK-ti cassette was attached at the end of 
the short arm for negative selection with FIAU. Targeted recombination between the vector and the wild-type IL-la locus results in the deletion 
of most of the IL-lb coding sequence, followed by its replacement with the neo gene. The probe used for detecting the targeted event was a 0.5 
kb Bglll fragment immediately downstream of the short arm. Digestion with the restriction endonucleases EcoRl and Kpnl were used to separate 
the wild-type and the targeted IL-lb alleles. EcoRl digestion generates a 7.6 kb wild-type band and a 3.8 kb targeted band and Kpnl digestion 
detects a 10 kb wild-type allele and a 16 kb targeted allele. B, BamHI; R, EcoRI; Bg, Bglll; K, Kpnl. PGK, phosphoglycerate kinase promoter. 
(B) Southern blot analysis of targeted clones. ES cell DNA (8 pg) from wild-type AB2.1 cells and two positive clones (214 and 334) were digested 
with restriction enzyme EcoRl (left) and Kpnl (right), electrophoresed on 0.8% and 0.6% agarose gels, respectively, transferred onto Gene Screen 
Plus nylon membranes (New England Nuclear DuPont), and hybridized with the 0.5 kb Bglll probe (see [A]). The diagnostic 3.8 kb EcoRl and 16 
kb Kpnl bands were detected in both clones. 
(C) Southern blot analysis of offspring from heterozygous matings. Genomic DNA isolated from tails of P-week-old pups generated from crosses 
of heterozygous mice was digested with EcoRI, transferred to membranes, and hybridized with the IL-la probe. +/+, wild-type; +/-, heterozygous; 
-I-, homozygous IL-1 B mutant mice. 
in iesponse to LPS injection in the IL-lb homozygous mu- 2). The expression of several liver acute-phase proteins, 
tant mice to a similar extent a8 in the wild-type controls including serum amyloid A (SAA), haptoglobin (HP), a-l 
(Table 1). The creation of a complete null allele was corrob- acid glycoprotein (a-AGP), and a-2 macroglobulin (azm) 
orated by demonstrating that IL-1 fl mRNA, although signif- were determined by quantitating the RNA levels following 
icantly expressed in response to LPS in the wild-type mice, LPS induction. Significant differences could not be de- 
could not be detected in the knockout animals (Figure tected in the amount of mRNA induced for any of the acute- 
_- -- -- -- I I I I +I+ +I+ Figure 2. Northern Blot Analysis of IL-15 Ex- 
/ pression Following LPS Induction 
* 2% Liver RNA was isolated from wild-type (+I+) 
‘Y 
/ 
and homozygous (-/-) IL-16 mice 3 hr after 
LPS injection using RNAzol B method (Biotecx 
Laboratories, Incorporated) and hybridized 
i, (1% 
with full-length IL-16 cDNA sequence. IL-15 
mRNA could not be detected in -I- mice follow- 
+. 
ing LPS injection. The lower panel shown in 
each caseisacontrol hybridization with mouse 
5-actin cDNA. Northern blot analysis was also 
performed using unchallanged mice. IL-1 5 ex- 
__-!..:/( I” 
pression could not be detected in control, un- 
phase proteins tested between the wild-type and the IL-1 j3- 
deficient mice (data not shown). This result is similar to 
that reported for LPS treatment of IL-6 knockout mice (Kopf 
et al., 1994; Fattori et al., 1994) suggesting that other 
cytokines, such as IL-la and TNFa, are able to induce 
these acute-phase proteins in the absence of IL-1 6 or IL-6. 
IL-1 p-Deficient Mice Are Resistant to 
Turpentlne-Induced Weight Loss 
Subcutaneous injection of turpentine into mice causes for- 
mation of a local sterile abscess and tissue injury, and 
results in a loss of body weight and synthesis of acute- 
phase proteins. Both IL-1 and IL-6 are induced by turpen- 
tine treatment, whereas TNFa is not (Gershenwald et al., 
1990). Experiments using IL-6 knockout mice or neutraliz- 
ing antibodies against IL-1 receptor reduced the inflamma- 
tory response induced by turpentine (Gershenwald et al., 
1990; Fattori et al., 1994). In our experiments, the body 
weight of both the wild-type and IL-16 knockout mice were 
followed and the change of body weight after turpentine 
injection was determined (Figure 3). As expected, the con- 
trol mice lost a significant amount of weight following tur- 
pentine treatment. Decreased body weight correlates with 
decreased food and water intake (data not shown). How- 
ever, the IL-1 P-deficient mice were resistant to turpentine- 
induced weight loss and anorexia, the body weight and 
food and water intake being in the same range as un- 
treated mice (Figure 3; data not shown). The weight gain 
in the first day and weight drop in the third day in the 
knockout mice apparently result from the extravasation 
and subsequent resorption of edema fluid at the local tur- 
pentine injection site as determined by observation of the 
swelling, which occurred at the injection site. 
The site of turpentine injection was examined micro- 
scopically. Both the wild-type and IL-18deficient mice ex- 
hibited local inflammation characterized by a cuff of inflam- 
matory cells, predominantly neutrophils, surrounding the 
cyst where turpentine had been injected. There were vari- 
able amounts of cellular infiltration, myofiber degenera- 
tion, and necrosis in the surrounding skeletal muscles. 
Although the two groups of mice showed dramatic pheno- 
typic differences in response to turpentine injection, there 
were no substantial differences in the nature and severity 
of the lesions between the control and IL-18 knockout 
mice. 
IL-lb Deficiency Results in a Lowered IL-6 Level and 
a Defective Acute-Phase Response Following 
Turpentine Treatment 
In the wild-type mice, there was a significant increase in 
plasma IL-6 when measured 8 hr after turpentine injection, 
but the turpentine-induced IL-6 expression was absent in 
the IL-18 knockout mice (Figure 4, p < 0.05 by student’s 
t test). The IL-la levels were also analyzed by enzyme- 
linked immunosorbent assay (ELISA) and these were be- 
low the sensitivity of detection in both the wild-type and 
IL-18deficient mice (data not shown). 
Inflammatory tissue damage results in the synthesis of 
hepatic acute-phase proteins. To determine the pattern 
of acute-phase protein induction following turpentine treat- 
Table 1. ELISA Analysis of Cytokine Levels Following LPS Induction 
rig/ml + SEM IL-16 IL-1 a TNFu IL-6 
Wild-type 0.60 f 0.04 0.23 f 0.03 61.2 f 6.6 193 f 13 
IL-1 5’ 0.00 f 0.00 0.21 f 0.05 41.4 f 12.3 156 f 41 
Both the wild-type (n = 11) and homozygous IL-15deficient mice (IL-lb-‘-) (n = 7) were sensitized by intraperitoneal injection of P. acnes and 
challenged by intraperitoneal injection of 10 pg LPS 6 days later as described in Experimental Procedures. Plasma and peritoneal fluid were 
prepared 3 hr after LPS injection and analyzed by ELISA to determine the concentrations of various cytokines. No significant difference was found 
comparing IL-la, 11-6, and TNFa levels induced in wild-type and IL-13 knockout mice. The data shown are the result of the analysis of plasma. 
ELISA analysis of peritoneal fluid produced similar results (data not shown). 
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Figure 3. Change in Body Weight Following Turpentine Treatment 
The body weight of male mice (n = 10) was measured daily before 
(days -2. -1). on (day 0). and following (days 1,2,3, and 4) turpentine 
injection. The change in weight relative to day -2 is shown. A group 
of 10 wild-type and IL-13 mutant mice were not infected and used 
as untreated controls. Open triangle, wild-type (+/+) untreated; open 
circle, wild-type (+I+) injected with turpentine; closed triangle, IL-15 
knockout mice(-/-) untreated; closed circle, IL-1 3 knockout mice (-/-) 
treated with turpentine. 
merit, liver RNA was isolated and the level of acute-phase 
protein expression (SAA, HP, AGP, and a,m) was quanti- 
fied by Northern blot analysis. The level of mRNA normal- 
ized with f3-actin is shown in Figure 5. Overall, there is a 
2- to g-fold reduction in SAA, HP, and aAGP expression 
in the knockout mice compared with the wild-type controls. 
mRNA levels are indicative of the levels of circulating pro- 
teins; an earlier report has shown that the serum plasma 
levels of these acute-phase proteins correlate well with 
the liver RNA levels (Kopf et al., 1994). We could not detect 
any a2m mRNA in the IL-1 B-deficient mice, although it was 
significantly induced in the wild-type animals (data not 
shown). The overall expression pattern of these acute- 
phase proteins in the IL-19 null mice is similar to that of 
the IL-9 knockout mice (Kopf et al., 1994; Fattori et al., 
1994) suggesting that the reduction in acute-phase pro- 
teins may be secondary to the lack of IL-6 induction in the 
IL-1 Bdeficient mice. 
LIehctive Fever Development in IL-1 jl 
Knockout Mice 
Both the control and IL-lb-deficient mice were implanted 
intra-abdominally with batteryoperated minitransmitters 
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Figure 4. ELlSAAnalysisof IL-3 LevelsFollowingTurpentineAdminis- 
tration 
Plasma (n = Mimepoint) was prepared from blood taken 0,3,24,48, 
72, and 98 hr after turpentine treatment from both the wild-type mice 
(+/+, open circle) and the IL-13 mutant mice (-I-, closed circle). The 
IL-6 level was determined by ELBA at different timepoints (p < 0.05 
comparing wild-type and IL-13 deficient mice at each timepoint, stu- 
dent’s t test). 
Figure 5. Acute-Phase Protein Expression Following Turpentine 
Treatment 
Liver total RNA was prepared at 0.8.24.43, and 72 hr after turpentine 
administration (n = 4Aimepoint) using standard procedures and hy- 
bridized with cDNAs for the following acute-phase proteins: SAA (A), 
HP (S), a-AGP (C) and arm (data not shown). +I+, wild-type controls; 
-I-, homozygous IL-lftdeficient mice. Probing with f3-actin was also 
performed and used as an internal standard. The values given were 
the averaged expression of each acute-phase protein normalized with 
f3-actin. 
to record body temperature. The mice were injected sub- 
cutaneously 2 weeks after surgery with either turpentine 
or with saline, and the body temperature and locomotor 
activity were monitored. When control mice were injected 
with turpentine, they responded with a profound fever, 
which started within 5 hr of injection and lasted approxi- 
mately 24 hr (Figure SA). Their average body temperature 
reached a peak of 39.4% f 0.04% 20 hr after the injec- 
tion and stayed elevated up to 35 hr following injection 
(Figure 6A). Following the fever, the wild-type mice under- 
went a period of hypothermia, as evidenced by the lack 
of normal circadian temperature rise during night 2 follow- 
ing the injection (Figure 66). The increase in body temper- 
ature was accompanied by a decrease of locomotor activ- 
ity (Figure 6C, day 0 to day 1). 
In contrast with control mice treated with turpentine, nei- 
ther body temperature nor locomotor activity were affected 
at any timepoint following turpentine injection in IL-l@ 
deficient mice, as evidenced by a complete overlap of both 
parameters with their saline-injected counterparts (Fig- 
ures 6A, 66, and 6C). The 12 hr average of body tempera- 
ture during night Ofor the IL-1 6 knockout mice injected with 
turpentine was 37.1 OC f 0.1 OC compared with 39.1 OC f 
0.06% for the turpentine-treated control mice (Scheffe, 
P = 0.0001). The rise in body temperature in the control 
group and IL-1 P-deficient mice at 9 hr and again at 34 hr 
is due to the normal circadian rise in body temperature. 
Interestingly, the basal locomotor activity of IL-16 knock- 
out mice was lower than that of the control group (Figure 
6C, p < 0.05). The reason for this is not clear. 
IL-1pDeflclent Mice Exhibit the Same Response 
In DTH and CH Reactions 
IL-16 has been implicated as a central mediator of DTH 
reactions. We characterized DTH and CH reactions in IL- 
16 knockout mice using two substances: the purified pro- 
tein derivative methylated bovine serum albumin (mBSA) 
was used for the DTH and the contact allergen oxazalone 
for the CH. In the DTH reaction, the mice were sensitized 
by skin injections to mBSA and challenged 7 days later 
by injection into one hind footpad. The contralateral foot- 
pad was injected with saline. The DTH response was mea- 
sured 24 hr later as the percentage of swelling in the paw 
injected with mBSAcompared with the saline-injected paw 
(Figure 7A). In addition, a nonsensitized control group was 
run in the same manner to ascertain the level of nonspe- 
cific swelling following mBSA injection. The results show 
that there is a significant DTH response in both the wild- 
type and the IL-1 6 knockout mice (sensitized versus non- 
sensitized, p < 0.001 for both groups), and the mean paw 
swelling between the control mice and the IL-l&deficient 
mice was not statistically different (p = 0.36). 
The CH reaction was determined by painting oxazalone 
on the abdominal skin to sensitize the mice. Mice were 
then challenged by painting oxazalone on one ear 5 days 
later. The CH response was measured as the difference 
in weight of biopsied section from the painted ear over 
the unpainted contralateral ear, determined 24 hr later. 
An equivalent CH response developed in the IL-16 null 
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Figure 6. Fever Induction Following Turpentine Injection 
129Sv(ev) inbred male mice were implanted with minitransmitters to 
monitor the body temperature. Mice were injected either with saline 
(wild-type, open triangle [+/+I; IL-1 6 knockouts, closed triangle [-I-]; 
n = 44group) or with turpentine (wild-type, open circle [+/+I; IL-16 
knockouts, closed circle I-/-], n = s/group). The body temperature 
and locomotor activity were automatically recorded both before and 
after injection. 
(A) Short-term temperature change following turpentine administra- 
tion. Note a complete lack of fever induction in the knockout mice 
following turpentine treatment. 
(6) Long-term body temperature measurement before and after turpen- 
tine injection. 
(C) Locomotor activity of wild-type (+/+) and IL-16deficient mice (-/-) 
before and after turpentine injection. 
mice compared with the wild-type controls (Figure 78, p = 
0.746). This result is in direct contrast with previous studies 
showing that an IL-l P-neutralizing antibody specifically in- 
hibited the CH response in mice (Enk et al., 1993). Taken 
together, the studies reported here suggest that IL-1 6 does 
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Figure 7. DTH Reactions 
(A) DTH to mBSA. Both the wild-type (+I+) and IL-15deficient (-/-) 
mice were either sensitized (closed bar) or nonsensitized (open bar) 
with mBSA and challenged by subsequent injection of mBSA into the 
left hindpaw. The DTH response was determined as the degree of 
swelling in the injected paw in the sensitized group. The value shown 
in the nonsensitized group represents nonspecific reaction (sensitized 
versus nonsensitized, p < 0.001 for both groups; sensitized, +/+ versus 
-I-, p = 0.55 by student’s t test). 
(B) DTH to contact allergen oxazolone. Both the control (+I+) and IL-1 5 
knockout (-/-) mice were either sensitized (closed bar) or nonsensi- 
tized (open bar) by applying oxazolone on the skin. Mice were chal- 
lenged 5 days later by painting oxazolone on one ear again. The other 
ear was not treated and used as a control. The DTH reaction was 
measured as the weight gain in the painted versus nonpainted ear. 
The value shown in the nonsensitized group represents nonspecific 
reaction (sensitized versus nonsensitized, p < 0.001 for both groups; 
sensitized, +/+ versus -/-, p = 0.745 by student’s t test). 
not play a crucial role in either CH or DTH reactions in 
the mouse. 
IL-lp-Deficient Mice Show the Same Susceptibllty 
to Murine Llateriosis 
To determine whether IL-1 P-deficient mice were impaired 
in their ability to mount a host defense response to the 
intracellular pathogen L. monocytogenes, a sublethal 
dose of 4.1 x lo3 organisms was injected intravenously 
into both the wild-type controls and IL-16 null mice. The 
mice were sacrificed 4 days after inoculation and the muiti- 
piication of L. monocytogenes in both spleen and liver was 
determined. The results showed that the wild-type and 
IL-1 6 knockout mice exhibited equivalent resistance to in- 
travenous challenge with L. monocytogenes. Spleen and 
liver organism counts were 6.34 f 0.37 and 4.92 f 0.30 
iogIO, respectively, in the knockout mice and 6.59 f 0.22 
and 5.13 f 0.49 iogIO, respectively, in the wild-typa mice 
(p = 0.562 and 0.772 between the wild-type and mutant 
mice in spleen and liver, respectively; student’s t test). 
Discussion 
IL-16 and the Cytokine Network 
IL-1 6 is regarded as a principal mediator of inflammation. 
We tested our IL-lj3 mutant mice against two different in- 
flammatory stimuli used in the experimental models: sys- 
temic inflammation caused by LPS injection, and turpen- 
tine-induced local tissue injury and inflammation. At 
various times up to 6 hr following injection of LPS, the 
levels of IL-1 a, iL-6, and TNFa were elevated to the same 
extent in the IL-16 knockout and wild-type mice, afthough 
IL-1 6 protein was not detected in the circulating blood or 
peritoneal fluids of the knockout animals (Table 1; data 
not shown). These results show that IL-la production is 
independent of the level of IL-16 in this model. Unexpect- 
edly, the phenotype of LPSchaiienged ICEdeficient mice, 
which are also defective in mature IL-1 6 production, differs 
in this regard as it appears that both the plasma levels of 
IL-1 a as well as IL-1 6 are greatly reduced (Li et al., 1995). 
Taken together, these data support the idea that interfer- 
ing with the ability of ICE to process IL-16 affects IL-la 
production. Similar to repotted resultsobtained using IL+- 
deficient mice, the hepatic acute-phase protein induction 
was not significantly altered in the IL-16 knockout mice. 
This result can be explained by cytokine redundancy, i.e., 
the loss of one cytokine, such as IL-16 or 11-6, can ba 
compensated for by other cytokines, such as IL-la and 
TNFa. Since TNFa is the earliest cytokine induced by LPS 
and is a major factor conferring endotoxin sensitivity to 
mice (Pfeffer et al., 1993) it is likely that TNFa plays a 
critical role in LPS-regulated events. Indeed, acute-phase 
protein elevations in mica injected with LPS were signifi- 
cantly suppressed by treatment of mice with an antibody 
to TNFa (Harbrecht et al., 1994). 
in contrast, TNFa is not induced by turpentine (Gershen- 
waid et al., 1990). Our results show that the turpentine- 
induced IL-6 elevation is diminished in the IL-16deficient 
mice, suggesting that IL-16 has a primary role in the ex- 
pression of IL-6 in this model. This may be viewed in the 
context of the cytokine network, wherein the loss of one 
cytokine, IL-1 6, results in the deficiency of another cyto- 
kine, IL-6. However, this does not rule out the possibility 
that IL-1 6 acts by more indirect mechanisms to affect IL-6 
expression. Likewise, the acute-phase protein expression 
pattern in the IL-16 knockout mice is similar to that of 
iL+deficient mice (Kopf et al., 1994; Fattori et al., 1994) 
suggesting that IL-16 indirectly induces acute-phase pro- 
tein expression through IL-6 up-regulation. 
IL-16 and Fever 
Body temperature is controlled in the thermoreguiatory 
center of the hypothalamus. Fever results from an ele- 
vated hypothalamic set point. Pathogenesis of fever in- 
valves the activation of macrophages by various exoge- 
nous pyrogens; for example, LPS or turpentine (Cooper 
and Rothwell, 1991; Kozaket al., 1994) which lead to the 
synthesis and release of endogenous pyrogens. Although 
IL-16 is considered to be a major endogenous pyrogen, 
other cytokines, such as IL-6 and TNFa, have been pro- 
posed to play important roles in fever development as well 
(reviewed by Kluger, 1991). Since the increase in IL-16 is 
usually accompanied by an increase in the IL-6 level, fever 
induction following LPS or turpentine treatment in wild- 
type animals may be caused by IL-1 or by an IL-1 -induced 
IL-Gexpression(LeMayetal.,1999;Kliretal.,1993,1994). 
Here, we show that the IL-lb-deficient mice are com- 
pletely resistant to turpentine-induced fever, demonstra- 
ting that IL-16 is critical in fever development. The com- 
plete inhibition of fever induction in the IL-16 null mice 
was surprising, since previous studies using neutralizing 
antibodies to IL-16 or IL-lra resulted only in partial sup 
pression of fever (Kluger, 1991). However, since IL-6 is 
not expressed in the absence of IL-16 following turpentine 
abscess, the resistance to fever development in the mu- 
tant mice could be due to the lack of either or both of these 
cytokines. In LPS-induced fever development, we show 
that although IL-6 is expressed at an equivalent level in 
both the IL-16deficient mice and wild-type controls, the 
temperature rise is suppressed by 50% in the mutant ani- 
mals (Kozak et al., 1995). This result suggests that al- 
though IL-16 itself is essential for fever induction, the de- 
velopment of a full blown fever may require both IL-16 
and 11-6. The confirmation of this hypothesis awaits the 
analysis of fever induction in IL&deficient mice. 
IL-lfl and DTH 
DTH response in mice is mediated by antigen-specific T 
cells and can be initiated by purified protein derivative or 
by contact allergens (Asherson and Ptak, 1966). Previous 
studies have shown that the induction of DTH reactions 
involve the production of several cytokines, such as IL-la, 
IL-16 11-6, TNFa, and interferon-y (IFNy) (Enk and Katz, 
1991; Ferreri et al., 1991; Chu et al,, 1992). Studies using 
recombinant IL-1 and neutralizing antibodies have shown 
that IL-16 may be important in initiating the CH response 
in skin, whereas blocking of IL-1 a and TNFa does not have 
a dramatic effect (Enk et al., 1993). Our results in models 
of both DTH to the purified protein derivative mBSA and 
CH to oxazolone in IL-16deficient mice show that IL-16 
is not required for either of these responses. Other cyto- 
kines, such as IL-l a, IL+ and TNFa may either compen- 
sate for the loss of IL-16 or they may play a primary role 
in these models. Although the reason for the discrepancy 
between our results and those described by Enk et al. 
(1993) is not clear, it raises the possibility that antibodies 
may elicit a more complex reaction. Our results are similar 
to thosedescribed by Fahertyet al. (1992), in whichadmin- 
istration of human IL-1 ra or a neutralizing antibody to type 
I IL-l receptor to mice failed to inhibit a variety of antigen- 
specific immune responses, including the CH reaction to 
oxazolone. Our data are in keeping with the large body 
of evidence suggesting that IL-1 is not required for normal 
lymphocyte development or responsiveness (Faherty et 
al., 1992; Arend, 1993). We predict agents that specifically 
block IL-1 6 will not be general immunosupressive agents. 
IL-lp and Host Defense 
Several cytokines have been proposed to be important 
in promoting immune responses to microbial pathogens. 
Murine resistance to the intracellular facultative bacterium 
L. monocytogens is a well-characterized model for this 
type of host defense and requires both T cell-dependent 
and independent activation of macrophages. IL-l, as well 
as 11-6, TNFa, and IFNy have been shown to be involved 
in this mechanism. In support of this, mice deficient for 
IL-6, TNF receptor ~55, and IFNy all showed a higher sus- 
ceptibility to L. monocytogenes infection (Dalton et al., 
1993; Pfeffer et al., 1993; Kopf et al., 1994). Our IL-lb- 
deficient mice, however, exhibited the same resistance to 
L. moncytogenes as the wild-type controls, suggesting 
that IL-la may be sufficient in murine resistance against 
Listeria. These data are in keeping with the failure of a 
neutralizing monoclonal antibody to IL-1 6 alone to potenti- 
ate Listeriosis in mice (Rogers et al., 1992). In contrast, 
IL-15 seems to be required for host defense against influ- 
enza virus infection, since the IL-1 6deficient mice showed 
a higher mortality rate following intranasal inoculation of 
influenzavirus ascompared with wild-type controls (Kozak 
et al., 1995). This is consistent with the observations that 
certain viruses produce potent inhibitors of IL-16 pro- 
cessing or soluble receptors, which preferentially bind IL- 
16 (Alcami and Smith, 1992; Ray et al., 1992; Spriggs et 
al., 1992). These results suggest that different cytokine 
networks are customized by the host and utilized for de- 
fense against different organisms. 
In this report, we explored the role of IL-16 in several 
inflammation models and we show that IL-16 is a crucial 
factor in the fever and anorexia development during local- 
ized inflammation induced by turpentine. In this model, 
IL-16 appears to control the expression of 11-6. Either IL-1 
alone or the combination of IL-1 and IL-6 contribute to 
the acute-phase responses following turpentine injection, 
including loss of body weight, acute-phase protein induc- 
tion, and, most dramatically, fever development. However, 
in the systemic inflammation model induced by LPS injec- 
tion and in DTH response, IL-16 does not seem to be 
essential. IL-1 has been implicated in a large number of 
disease models, such as islet destruction (Corbett and 
McDaniel, 1995) cartilage destruction (Geiger et al., 1993) 
and allograft rejection (Fanslow et al., 1990). The IL-15 
knockout mice reported here should provide a valuable 
tool to address the function of this cytokine and its role 
as a target for pharmaceutical intervention in these and 
other models of inflammation and disease. 
ExperImental Procedure8 
Constructlon of IL-lb Deletion Vector and GeneratIon 
of IL-lb Null Mice 
The mouse IL-1p genomic sequence was isolated by screening a 
mouss cosmid library derived from 129Sv strain of ES cells using 
mouss IL-lb cDNA as a probe (Telford et al., 1996). The isolated clone 
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contained the entire coding region of the IL-15 gene as well as 5’ 
promoter region of the gene. 
The 1.3 kb Kpnl-Bglll fragment encoding exon 7 of the IL-15 gene 
was made blunt and cloned into the blunt-ended EcoRl site of 
pGEM7(tk) vector containing the PGK-dk cassette. A 1.8 kb PGK-neo 
fragment was inserted up&ream of the 1.3 kb IL-1 b sequence. A 4.0 
kb BamHl fragment containing 5’ noncoding region of the IL-I 5 gene 
was inserted upstream of the neo cassette. A 5.6 kb sequence from 
BamHl site to Kpnl site encoding part of exon 1 to intron 6 of the IL-I j3 
gene was deleted. The final targeting vector was linearized by Sall 
digestion, which cuts downstream of the f/r sequence prior to electro 
poratton. 
Electroporation and blastocyst injection were performed as de 
scribed (Zheng et al., 1995). 
Anlmal Csre and treatment 
Mice were housed in a virus antibody-free facility and the care of ani- 
mals were conducted as approved by the lnstttutional Animal Care 
and Use Committee of Merck and Company, Incorporated. Mice of 
mixed C57BU6J and 129Sv(ev) background were used for all studies 
except fever experiments, in which Case inbred 129Sv(ev) strain was 
used, which w re produced by breeding the chimeras with 129Sv(ev) 
females (Taco ic). 
For LPS inj 
t 
ion, both the wild-type and IL-18 knockout mice about 
8 weeks old (n = 7) were sensitized by intraperitoneal injection of 1 
mg P. acnes in 1 ml saline and challenged by intraperitoneal injection 
of 10 ug LPS in 0.5 ml saline 8 days later to induce the expression 
of IL-1 5 and other cytokines. Mice were sacrificed 3 hr after challenge 
byCO* asphyxiation. Heparinized blood was obtained by cardiac punc- 
ture. The peritoneal cavities were lavaged with 2 ml heparinized saline. 
Both the cell-free plasma and lavage fluids were prepared by centrifu- 
gation and stored at -70°C until cytokine analysis by ELISA. Liver 
RNA was prepared from the same micB and Northern hybridizations 
were carried out by standard procedures using the mouse IL-15 cDNA 
as a probe. 
In the turpentine-induced sterile abscess model, male mice at ap- 
proximately 9 to 10 weeks of age (n = 1 O/group) were injected subcuta- 
neously with 100 ul of commercial grade steam-distilled wood turpen- 
tine (Sunneyside Corp., Wheeling, Illinois) into the left hindlimb. At 0, 
8,24,48,72, and 96 hr following turpentine treatment, the body weight 
was measured, and groups of mice were sacrificed by CO, asphyxia- 
tion. A group of 10 mice of both the wild-type and knockout animals 
were maintained as noninjected controls and their body weight was 
determined at the same timepoints. Hepartnized blood was collected 
by cardiac puncture. Plasma was prepared and used to determine the 
IL-6 levels. Liver RNA was isolated and used for analysis of acute- 
phase protein expression. 
For temperature measurements and fever induction, the deep body 
temperatures of the mice were measured with an accuracy of f 0.1 OC 
using a battery-operated biotelemetry device (model VMFH MiniMitter, 
Sunriver, Oregon) implanted intra-abdominally using aseptic surgical 
conditions. The transmitters (dimensions: 13 x 18 mm; weight, 2.5 
g) were coated with surgical wax, calibrated, and soaked overnight 
in Cidex for sterilization before surgery. For implantation, mice were 
anesthetized with halothane, a small incision was made through the 
skin and abdominal muscles (- 1.5 cm), and then the transmitter, first 
rinsed with a pyrogen-free isotonic sodium chloride, was implanted 
into the abdominal cavity. Muscle and skin were sutured separately 
with absorbable Vicryt sutures and the animals allowed to recover 14 
days before experimentation. Experiments were started after a regular 
rhythm of body temperature and locomotor activity in freely moving 
mice had been monitored for at least 3 days. Recordings were made 
at 5 min intervals using a peripheral processor (Dataquest Ill System) 
connected to an IBM personal computer. After 2 weeks, mice were 
divided into four groups, anesthetized with halothane, and injected 
(subcutaneously) either with steamdistilled turpentine (n = 5) or with 
saline (n = 4) (100 pl per animal) into the left hindlimb. Body tempera- 
ture measurements were then continued. The locomotor activity of 
the mice was measured using the same biotelemetry system described 
above. In brief, changes in activity were detected by changes in the 
position of the implanted transmitter over the receiver board. This 
results in a change in the signal strength that is detected by the receiver 
and recorded as a ‘pulse” of activity. 
In the DTH reaction to mBSA, 20 IL-15 knockout mice and 20 wild 
type controls were used. In each group, IO mice were sensitized by 
three subcutaneous injections on the dorsum of each mouse, using 
a total of 25 ug mBSA in 300 pl saline:CFA (l:l). The remaining IO 
mice in each group were not injected and constituted the nonsensttized 
groups. Each mouse was injected subcutaneously into the left hind 
footpad with 25 pl of IO mglml mBSA in saline 7 days later. The vol- 
umes of both the uninjected right and the injected left hind paw were 
determined 24 hr later for each mouse using a mercury plethysmo 
graph. The difference between the injected and uninjected paws were 
calculated and the DTH response was expressed as a percent increase 
of the injected paw. The nonspecific response is represented by the 
paw swelling in the nonsensitized groups. Salineinjected paws were 
found to return to normal volume within 24 hr and, therefore, this 
control group was not routinely run. 
For testing of contact sensitivity to oxazolone, mice were sensitized 
by shaving the abdominal area of each mouse, applying 100 PI 4% 
4-ethoxymethytene-2-phenyl-2-oxazolin-5-one (oxazofone, Sigma, St. 
Louis, Missouri) in acetone to the skin, and allowing it to dry. Mice 
were challenged 5 days later by painting both sides of one ear with 
50 ul 1% oxazolone in acetone, leaving the contralateral ear as a 
control. The mice were euthanized 24 hr later by COZ asphyxiation. 
A disc of ear tissue was removed from both ears of each mouse, 
using a 6 mm biopsy punch, and weighed. The difference between 
the painted and unpainted ear weights for each mouse was taken as 
the amount of swelling occurred in response to oxazolone. A nonsensi- 
tized control group was run in each experiment to determine the 
amount of swelling that occurred in response to the ear challenge 
alone. Results are expressed as the change in weight due to oxszolone 
challenge f SEM (n = 10). 
For host defense experiment, the wild-type and IL-18 null mice (n = 
4/group) were challenged by intravenous infection with 4.1 x 105 L. 
monocytogenes. The mice were euthanized 4days later and the organ- 
ism enumerated as described (Rosen et al., 1989). 
Dats Analysis 
For fever experiment, data were analyzed using Statview SE+Graph- 
its (Abacus Concepts, Berkeley, California). Analysis of variance (AN- 
OVA) with repeated measures was used to determine differences 
among groups in patterns of temperature and activity changes over 
time. ANOVA followed by Scheffe pairwise comparisons was used to 
test for statistical differences among groups at individual timepoints. 
Analysis of ELISA, DTH, and host defense data were performed by 
student’s t test. 
ELISA Aaeeys 
ELlSAsweredeveloped for murtne IL-1 a, 11-15. and IL-6 using antibod- 
ies as described in Molineaux et al. (1993). A monoclonal antibody to 
IL-15wasprovided by Dr. D. Chaplin (Washington University, St. Louis, 
Missouri). A polyclonal antibody to murine TNFa was purchased from 
Genzyme (Cambridge, Massachusetts). The ELISA sensitivity was 
0.05 nglml. 
Acute-Phase Proteln ExpmssJons 
Liver RNA from control and IL-18 mutant mice (4 each) was isolated 
at 0,8,24,48, and 72 hr following turpentine injection by homogenizing 
the tissue in guanidine isothiocyanate and probed with =P-labeled 
cDNAs for mouse SAA (Sipe et al., 1993) rat HP (Baumann et al., 
1986), rat a-AGP (Baumann et al., 1986) and rat aim (Northemann 
et al., 1985). The same filters were also hybridized with mouse 5-actin 
for loading control. The intensity of each acute-phase protein was 
quantified using phosphorimager and normalized to @actin. 
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